已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Clinical Relevance of Pretransplant Testing for Anti-Human Leukocyte Antigen Antibodies in Iraqi Renal Transplant Patients

医学 人类白细胞抗原 抗体 内科学 肾移植 胃肠病学 临床意义 输血 供体特异性抗体 补体依赖性细胞毒性 移植 免疫学 抗原 单克隆抗体 抗体依赖性细胞介导的细胞毒性
作者
Ala Ali,Aroub Abdul Rahman Al-Kaisi,Imran Ali
出处
期刊:Experimental and Clinical Transplantation [Başkent University]
卷期号:17 (Suppl 1): 164-168 被引量:1
标识
DOI:10.6002/ect.mesot2018.p40
摘要

The use of highly sensitive Luminex technology to assess the immunologic risk of renal transplant candidates have greatly added to the ability of stratifying patients and have paved the way to avoid hyperacute antibody-mediated rejection. Our aim was to understand how much the testing for pretransplant anti-HLA antibodies affects the decision for transplant and survival at 1 year posttransplant.From January 2014 to June 2017, 336 transplant candidates were tested by complement-dependent cytotoxicity and by the Luminex platform for anti-HLA antibodies in our nephrology and renal transplant center (The Medical City, Baghdad, Iraq). All clinical and laboratory data were noted. Our program is a living-donor, blood group-compatible donor program. All transplant patients (sensitized or not) were followed for 1 year, and the Kaplan-Meier method was used to determine survival rate.Mean age of the study group was 34.07 ± 12.4 years. Of 336 transplant patients who were tested, there were 63 (18.75%) sensitized patients and 159 (47.35%) nonsensitized patients. Blood transfusion was the main cause of sensitization. Class I anti-HLA antibodies were detected in 54 of 63 sensitized patients (85.7%), and class II anti-HLA antibodies were detected in 39 of 63 sensitized patients (61.9%). Donor-specific antibodies were detected in 33/63 (52.3%). Thirteen sensitized patients (15.3%) underwent transplant. No incidences of hyperacute rejection were recorded. The 1-year survival of the nonsensitized patient group was 90%, whereas survival was 61.5% for the sensitized patient group.Pretransplant testing for anti-HLA antibodies is undoubtedly useful for assessment of patient risk, to facilitate decisions regarding patient and donor selection, and to plan treatment strategies. The 1-year survival for sensitized patient was lower than for nonsensitized patients. More knowledge, experience, technology advancements, and support are needed to improve the Iraqi practice of transplanting sensitized patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
等璃子发布了新的文献求助10
刚刚
1秒前
1秒前
哈哈发布了新的文献求助10
2秒前
vv发布了新的文献求助10
2秒前
4秒前
su完成签到 ,获得积分10
4秒前
隐形曼青的应助被Page_Page采纳,获得30
5秒前
科研狗完成签到,获得积分10
6秒前
七七完成签到,获得积分10
6秒前
6秒前
朱海兰发布了新的文献求助10
7秒前
8秒前
7766发布了新的文献求助30
8秒前
Owen的应助被科研通管家采纳,获得10
8秒前
8秒前
田様的应助被科研通管家采纳,获得10
8秒前
wheat的应助被科研通管家采纳,获得10
8秒前
小马甲的应助被科研通管家采纳,获得10
9秒前
微风发布了新的文献求助10
9秒前
科研狗发布了新的文献求助10
10秒前
怕黑凤妖完成签到 ,获得积分10
10秒前
Hase发布了新的文献求助30
11秒前
激情的冰绿完成签到 ,获得积分10
11秒前
小旋风完成签到,获得积分10
13秒前
13秒前
13秒前
15秒前
xc完成签到 ,获得积分10
16秒前
罗斌奇发布了新的文献求助20
16秒前
强健的寻云完成签到 ,获得积分10
17秒前
唯唯完成签到 ,获得积分10
19秒前
求求毕业发布了新的文献求助10
19秒前
李博文发布了新的文献求助10
20秒前
tiantianyuan完成签到 ,获得积分10
21秒前
坚定初阳完成签到 ,获得积分10
21秒前
h123完成签到,获得积分10
23秒前
25秒前
epmoct完成签到 ,获得积分0
25秒前
Gideon完成签到,获得积分10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165423
求助须知:如何正确求助?哪些是违规求助? 9559005
关于积分的说明 21748579
捐赠科研通 7756086
什么是DOI,文献DOI怎么找? 3428919
关于科研通互助平台的介绍 2553193
邀请新用户注册赠送积分活动 2473473